LEGACY Trial of Radioembolization Shows Practice-Changing Data in HCC
Michael R. Charlton, MD, MBBS, discusses the impact of the LEGACY trial investigating yttrium-90 radioembolization in patients with solitary, unresectable hepatocellular carcinoma.
Studies Investigate Multiple Types of Therapies in HCC
Michael R. Charlton, MD, MBBS, discusses different types of therapy and trials in the hepatocellular carcinoma setting right now.
2 Clarke Drive Cranbury, NJ 08512